Evidence map›Paper›PMID 35303833›Full record

ArticleBMC pulmonary medicine2022

Systemic inflammation and sympathetic activation in gestational diabetes mellitus with obstructive sleep apnea.

Oleksandr Serednytskyy, Alberto Alonso-Fernández, Caterina Ribot, Andrea Herranz, Ainhoa Álvarez, Andrés Sánchez, Paula Rodríguez, Ana V Gil, Carla Pía, José P Cubero and 11 more

Open access · goldAbstract read
In one paragraph

Article in BMC pulmonary medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Oleksandr SerednytskyyInstitut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Balearic Islands, Spain.
Alberto Alonso-FernándezInstitut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Balearic Islands, Spain. aaf_97@hotmail.com.
Caterina RibotInstitut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Balearic Islands, Spain.
Andrea HerranzInstitut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Balearic Islands, Spain.
Ainhoa ÁlvarezUnidad del Sueño, Hospital Universitari de Araba, Vitoria-Gasteiz, Ávala, Spain.
Andrés SánchezServicio de Neumología, Hospital Universitario Miguiel Servet, Zaragoza, Zaragoza, Spain.
Paula RodríguezInstituto de Investigación BIOARABA, Vitoria-Gasteiz, Ávala, Spain.
Ana V GilInstituto de Investigación Sanitaria de Aragón, Zaragoza, Spain.
Carla PíaInstituto de Investigación BIOARABA, Vitoria-Gasteiz, Ávala, Spain.
José P CuberoInstituto de Investigación Sanitaria de Aragón, Zaragoza, Spain.
María BarcelóInstitut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Balearic Islands, Spain.
María CerdàServicio de Neumología, Hospital Palma Planas, Palma, Balearic Islands, Spain.
Mercedes CodinaServicio de Endocrinología, Hospital Universitari Son Espases, Palma, Balearic Islands, Spain.
Mónica D PeñaInstitut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Balearic Islands, Spain.
Antònia BarcelóInstitut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Balearic Islands, Spain.
Amanda IglesiasInstitut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Balearic Islands, Spain.
Daniel Morell-GarciaInstitut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Balearic Islands, Spain.
José A PeñaInstitut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Balearic Islands, Spain.
María P GiménezInstitut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Balearic Islands, Spain.
María C PiñasInstitut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Balearic Islands, Spain.
Francisco García-RíoServicio de Neumología, Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
Health Research Institute of the Balearic Islands · ESInstituto de Investigación Sanitaria Aragón · ESHospital Universitario Araba · ESHospital Universitario La Paz · ESHospital Universitario Son Espases · ES

Funding

Ministerio de Ciencia, Innovación y Universidades (PI19/00875) PI19/00875Ministerio de Economia y Competitividad (PI11/00495) PI11/00495Sociedad Española de Neumología y Cirugía Torácica SEPAR-2020-820
6 · The paper itself

Abstract

backgroundAlthough some evidence suggests an association between obstructive sleep apnea (OSA) and gestational diabetes mellitus (GDM), its consequences still remain largely unknown. We sought to determine whether OSA is associated with higher inflammation and sympathetic levels in GDM, and to relate them with insulin resistance and perinatal outcomes.

methodsOSA was identified by polysomnography and defined as an apnea-hypopnea index of ≥ 5 h

resultsWe included 17 patients with GDM and OSA and 34 without OSA. Women with GDM and OSA had higher normetanephrine concentrations [81 IQR (59-134) vs. 68 (51-81) pg/mL]. No differences in the inflammatory profile were found, while IL-1β was higher in patients with mean nocturnal oxyhemoglobin saturation ≤ 94%. We found positive correlations between increased sympathetic activation and IL-1β, with obstructive apneas, while time in REM showed an inverse relationship with IL-1β and metanephrine. Furthermore, IL-10 was inversely related with time in sleep stages 1-2, and with the arousal index, and it was positively related with time in slow-wave sleep. Significant correlations were also found between IL-1β and insulin resistance. There were no significant differences in neonatal characteristics; however, we found inverse relationships between IL-10 and birth weight (BW), and percentile of BW.

conclusionsOSA increased sympathetic activity, and IL-1β concentration was higher in patients with GDM with lower nocturnal oxygenation, all of which were related with obstructive events, and time in REM. Moreover, IL-1β was related with insulin resistance, and IL-10 inversely correlated with neonatal BW.

Indexed as

Diabetes, GestationalInsulin ResistanceSleep Apnea, ObstructiveFemaleHumansInfant, NewbornInflammationPolysomnographyPregnancyCytokine; inflammationFetal outcomesGestational diabetes mellitusMetanephrineNormetanephrineObstructive sleep apnea

Identifiers

PMID35303833
PMCPMC8933971
OpenAlexW4221062021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.